# FDA Inspection 1204190 - Bertrand Arnulf, MD, PhD - April 07, 2023

Source: https://www.keypedia.com/records/fda_inspections/bertrand-arnulf-md-phd/091f7c17-8ae6-4d23-a557-c4965ba60992
Source feed: FDA_Inspections

> FDA Inspection 1204190 for Bertrand Arnulf, MD, PhD on April 07, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204190
- Company Name: Bertrand Arnulf, MD, PhD
- Inspection Date: 2023-04-07
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/bertrand-arnulf-md-phd/c167dcee-cc62-4160-a16f-53a45c4a8ec2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c